Get the Stockscreener App
4.2015
0.99%
0.0415
Maxcyte Inc stock is traded at $4.2015, with a volume of 139.56K.
It is up +0.99% in the last 24 hours and up +15.74% over the past month.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
See More
Previous Close:
$4.16
Open:
$4.02
24h Volume:
139.56K
Relative Volume:
0.28
Market Cap:
$438.81M
Revenue:
$45.44M
Net Income/Loss:
$-35.43M
P/E Ratio:
-13.13
EPS:
-0.32
Net Cash Flow:
$-25.39M
1W Performance:
+3.22%
1M Performance:
+15.74%
6M Performance:
+12.94%
1Y Performance:
-15.98%
1-Day Range:
$4.015
$4.25
1-Week Range:
$3.965
$4.375
52-Week Range:
$3.165
$5.545
Maxcyte Inc Stock (MXCT) Company Profile
Name
Maxcyte Inc
Sector
Industry
Phone
301-517-5556
Address
9713 KEY WEST AVENUE,, ROCKVILLE
Compare MXCT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
4.21 | 438.81M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
113.45 | 196.18B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
359.57 | 137.26B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
89.62 | 131.64B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
80.26 | 102.43B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.22 | 43.66B | 6.60B | 4.16B | 490.10M | 6.93 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-23 | Initiated | Craig Hallum | Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-24-21 | Initiated | BTIG Research | Buy |
| Aug-24-21 | Initiated | Cowen | Outperform |
| Aug-24-21 | Initiated | Stephens | Overweight |
| Aug-24-21 | Initiated | Stifel | Buy |
| Aug-24-21 | Initiated | Wedbush | Outperform |
| Aug-24-21 | Initiated | William Blair | Outperform |
View All
Maxcyte Inc Stock (MXCT) Latest News
Franklin Resources Inc. Makes New Investment in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
Geode Capital Management LLC Grows Holdings in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
Barclays PLC Grows Holdings in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte director sells shares after option exercise By Investing.com - Investing.com South Africa
Art Mandell Retires from MaxCyte Board - citybiz
MaxCyte director sells shares after option exercise - Investing.com India
MaxCyte Director Exercises Stock Options and Executes Sales - TipRanks
MaxCyte, Inc. (NASDAQ:MXCT) Director Sells $12,030.00 in Stock - MarketBeat
Maxcyte director Johnston sells shares worth $12,020 - Investing.com
MaxCyte Announces Leadership Transition and Strategic Focus - MSN
State Street Corp Grows Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Streamlines Workforce and Boosts Revenue Outlook - MSN
MaxCyte, Inc. Announces Retirement of Board Member Art Mandell - Marketscreener.com
MaxCyte board member Art Mandell retires - Investing.com India
MaxCyte board member Art Mandell retires By Investing.com - Investing.com Canada
MaxCyte Announces Retirement of Board Member Art Mandell - The Manila Times
MaxCyte Announces Board Member Retirement - TipRanks
MaxCyte Board Member Art Mandell to Exit After 18-Year Tenure Marked by Landmark CRISPR Achievements - StockTitan
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 27,111 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Announces Change in Shareholder Voting Rights Due to BlackRock Holdings - TipRanks
BlackRock Adjusts Stake in MaxCyte, Influencing Voting Rights - TipRanks
MaxCyte (LON:MXCT) Shares Up 3.4%Here's Why - MarketBeat
MaxCyte (LON:MXCT) Shares Up 3.4% – Here’s Why - Defense World
Fmr LLC Lowers Stake in MaxCyte, Inc. (NASDAQ:MXCT) - MarketBeat
MaxCyte cuts 15% of global workforce, boosts core revenue guidance - MSN
MaxCyte, Inc. Announces Change in Major Holdings by BlackRock - TipRanks
MaxCyte Announces Change in Major Shareholdings - TipRanks
Getting In Cheap On MaxCyte, Inc. (LON:MXCT) Might Be Difficult - Simply Wall St
MaxCyte Shares Surge On Boost to Revenue-Growth Outlook - MarketWatch
MaxCyte ups core revenue guidance for 2024 as eyes 2025 cost savings - Marketscreener.com
MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance Provide Update - citybiz
MaxCyte Inc slashes workforce by 15%, ups revenue forecast - TradingPedia
MaxCyte upgrades revenue guidance after operational review - ShareCast
MXCTMaxCyte, Inc. Latest Stock News & Market Updates - StockTitan
Intech Investment Management LLC Purchases New Shares in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance - The Manila Times
MaxCyte cuts 15% of global workforce, boosts core revenue guidance (NASDAQ:MXCT) - Seeking Alpha
MaxCyte Restructures with 15% Job Cuts, Boosts 2024 Revenue Growth Outlook to 8% - StockTitan
ArrowMark Colorado Holdings LLC Purchases 169,250 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - MarketBeat
MaxCyte Expands Stock Capital Amid Cell Therapy Growth - TipRanks
MaxCyte Sees Shift in BlackRock’s Shareholding - MSN
MaxCyte’s Voting Rights Shift with BlackRock Acquisition - MSN
MaxCyte, Inc. (NASDAQ:MXCT) Shares Purchased by Mudita Advisors LLP - MarketBeat
Electroporation Enables Efficient Antibody Discovery By Mammalian Display - BioProcess Online
Accelerate Antibody Development And Production - BioProcess Online
This MaxCyte Insider Increased Their Holding In The Last Year - Yahoo Finance
MaxCyte celebrates 25 years of innovation driving cell engineering-based therapeutics - MSN
Maxcyte Inc Stock (MXCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Maxcyte Inc Stock (MXCT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Johnston John Joseph | Director |
Dec 26 '24 |
Sale |
4.01 |
3,000 |
12,021 |
141,950 |
0.66%
2.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):